Department of Interventional Vascular Surgery, Binzhou Medical University Hospital, Binzhou, China.
Key Laboratory of Metabolism and Molecular Medicine, The Ministry of Education, Department of Biochemistry and Molecular Biology, Fudan University Shanghai Medical College, Shanghai, China.
Vascular. 2021 Jun;29(3):468-471. doi: 10.1177/1708538120957478. Epub 2020 Oct 14.
Primary leiomyosarcoma in the femoral vein is an extremely rare vascular disorder and is often misdiagnosed. In order to improve the knowledge and treatment of this disease, a case of leiomyosarcoma in the femoral vein was reported.
We report the case of a 58-year-old woman with a leiomyosarcoma of the femoral vein and treated successfully by surgical resection. After surgery, no recurrence had been noted follow-up.Subsequently, we reviewed information derived from 31 previously published cases from 1954 to 2019.
A total of 31 patients diagnosed with femoral vein leiomyosarcoma were presented in previous studies; in all of these patients, 14 (45.2%, 14/31) patients were men. Of these, the median age was 51.6 years old (ranging from 3 to 84).
Complete resection with adjuvant chemotherapeutic was the main strategy to treat the disease. Prognosis remains poor if metastasis was present, especially pulmonary metastasis.
股静脉原发性平滑肌肉瘤是一种极为罕见的血管疾病，常被误诊。为了提高对这种疾病的认识和治疗水平，报告 1 例股静脉平滑肌肉瘤病例。
报告 1 例 58 岁女性股静脉平滑肌肉瘤患者，经手术切除治疗成功。术后随访未见复发。随后，我们复习了 1954 年至 2019 年期间 31 例既往发表的病例资料。
既往研究共报告 31 例股静脉平滑肌肉瘤患者；所有患者中，14 例（45.2%，14/31）为男性，中位年龄为 51.6 岁（范围 3-84 岁）。
完整切除加辅助化疗是治疗该病的主要策略。如果存在转移，尤其是肺转移，预后仍然很差。
